about
Interactions between kidney disease and diabetes: dangerous liaisonsThe treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapiesManagement of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic controlAdverse safety events in patients with Chronic Kidney Disease (CKD).Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.A review of the pharmacological properties of insulin degludec and their clinical relevance.Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with moderate to severe renal impairment: a systematic review and meta-analysisType 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients.Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?Insulin degludec: pharmacokinetics in patients with renal impairment.Consensus Statement on Dose Modifications of Antidiabetic Agents in Patients with Hepatic Impairment.Incretin therapies in the management of patients with type 2 diabetes mellitus and renal impairment.Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes.Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment.Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease.Hypoglycemia in Hospitalized Hemodialysis Patients With Diabetes: An Observational Study.Impact of a Basal-Bolus Insulin Regimen on Metabolic Control and Risk of Hypoglycemia in Patients With Diabetes Undergoing Peritoneal Dialysis.End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State.EADSG Guidelines: Insulin Therapy in Diabetes.What is the frequency of carbohydrate metabolism disorder in CKD?Treatment of Hyperkalemia With a Low-Dose Insulin Protocol Is Effective and Results in Reduced Hypoglycemia.
P2860
Q26740630-962A4AD8-5D34-4C6D-945E-8638A8516F5CQ26744317-F2AA23F9-D1FD-4CD8-873B-8515DB413CD3Q26766259-41D54BB2-D452-429C-92D8-292FD5F82A51Q30245199-E3E1F5E0-7BA0-487E-BE04-040D0DE63C80Q31025919-0F7A06F4-E2D1-4054-A97F-674B260038C8Q34436383-7D9235AF-A921-4A90-961C-C18231F19365Q35382193-4B47A9F0-7025-41AD-9DF5-A3DCC30672BCQ35597739-61433D7B-DBB7-45E6-BD11-E9A5302A02DEQ36818863-218BF7A7-AE21-4DE7-BCB7-116DFE747B52Q37127547-0D709002-254B-4528-A56F-55569B699C41Q37506526-249ED7C0-3525-44BB-A3AE-BABAF058D892Q37721962-7004B579-9052-41EA-AEAD-5AEC9FE21DD2Q38012068-23F95B5B-B704-443A-9497-02D02D4A7DBCQ38054558-2FEBC8DD-763E-49CD-87BB-32383FBDC941Q38378906-804DEB29-2FD0-4A68-A586-B4E82F9ADF0CQ38543658-8849EADD-EFED-431B-9365-BE2A6269E1C1Q47226759-F32F1BF8-540F-4BE0-B32D-3ED8815225DCQ50016718-7F6A65C9-CD0C-4E2F-ADFF-A4EA0C7E635DQ50131260-0C263BB3-CB12-4515-BAC6-B80439DBD7F7Q51245935-01021C52-8C64-4AEB-ACAA-34698B04C576Q51368264-8427FD0B-066E-4811-B611-48A32DCFE5DFQ55260411-EFE8F431-CCFF-4001-95ED-4F678DB9CABC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin therapy in renal disease.
@en
Insulin therapy in renal disease.
@nl
type
label
Insulin therapy in renal disease.
@en
Insulin therapy in renal disease.
@nl
prefLabel
Insulin therapy in renal disease.
@en
Insulin therapy in renal disease.
@nl
P2860
P1476
Insulin therapy in renal disease.
@en
P2093
Juan J Díez
Pedro Iglesias
P2860
P304
P356
10.1111/J.1463-1326.2007.00802.X
P577
2008-02-01T00:00:00Z